Platelet-rich plasma for managing pain and inflammation in osteoarthritis.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 24080861)

Published in Nat Rev Rheumatol on October 01, 2013

Authors

Isabel Andia1, Nicola Maffulli

Author Affiliations

1: Regenerative Medicine Laboratory, BioCruces Health Research Institute, Cruces University Hospital, Plaza Cruces S/N, 48903 Barakaldo, Spain.

Associated clinical trials:

Intra-operative PRP Injection Following Partial Meniscectomy (PRP-MEN) | NCT02872753

Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction. | NCT04396795

Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction (COCKTAIL) | NCT05048667

Articles citing this

Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J (2014) 1.49

Platelet-rich plasma treatment improves outcomes for chronic proximal hamstring injuries in an athletic population. Muscles Ligaments Tendons J (2015) 1.47

Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop (2014) 1.11

Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther (2014) 1.04

Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trial. Orthop Rev (Pavia) (2014) 0.94

Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience. Muscles Ligaments Tendons J (2014) 0.87

Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci (2015) 0.81

Hyperuricemic PRP in tendon cells. Biomed Res Int (2014) 0.81

Platelet-rich plasma: Renewed scientific understanding must guide appropriate use. Bone Joint Res (2016) 0.81

Angiogenic and innate immune responses triggered by PRP in tendon cells are not modified by hyperuricemia. Muscles Ligaments Tendons J (2014) 0.81

Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. Am J Sports Med (2015) 0.80

Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification. J Cell Commun Signal (2015) 0.79

Anti-inflammatory strategies in cartilage repair. Tissue Eng Part B Rev (2014) 0.78

Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord (2016) 0.78

Management of Osteoarthritis with Avocado/Soybean Unsaponifiables. Cartilage (2015) 0.78

Platelet rich plasma therapies: a great potential to be harnessed. Muscles Ligaments Tendons J (2014) 0.78

Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res (2015) 0.78

In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide. BMC Vet Res (2016) 0.77

Adipose-derived mesenchymal stem cells and platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis in Beagle dogs. J Orthop Surg Res (2016) 0.77

Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro. Reprod Biol Endocrinol (2016) 0.75

Site-specific targeting of platelet-rich plasma via superparamagnetic nanoparticles. Orthop J Sports Med (2015) 0.75

Articular cartilage tissue engineering: the role of signaling molecules. Cell Mol Life Sci (2016) 0.75

TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis. Cell Death Dis (2017) 0.75

Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study. Biomed Res Int (2016) 0.75

Therapeutic efficacy of intra-articular hyaluronan derivative and platelet-rich plasma in mice following axial tibial loading. PLoS One (2017) 0.75

Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration. Curr Stem Cell Rep (2016) 0.75

The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res (2017) 0.75

Three-dimensional culture environment increases the efficacy of platelet rich plasma releasate in prompting skin fibroblast differentiation and extracellular matrix formation. Int J Med Sci (2014) 0.75

We are operating too much. J Orthop Traumatol (2017) 0.75

Zoon Vulvitis Treated Successfully With Platelet-Rich Plasma: First Case Reported. J Low Genit Tract Dis (2017) 0.75

Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis. Clin Exp Med (2017) 0.75

Efficacy and safety profile of a compound composed of platelet-rich plasma and hyaluronic acid in the treatment for knee osteoarthritis (preliminary results). Eur J Orthop Surg Traumatol (2015) 0.75

Effects of Autologous Platelet-Rich Plasma on Regeneration of Damaged Endometrium in Female Rats. Yonsei Med J (2017) 0.75

Articles cited by this

(truncated to the top 100)

Making sense of latent TGFbeta activation. J Cell Sci (2003) 8.90

Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A (2002) 4.46

Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost (2004) 4.26

Osteoarthritis: an update with relevance for clinical practice. Lancet (2011) 4.18

Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med (2013) 3.57

Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil (2012) 3.48

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood (2007) 3.38

Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol (2009) 3.19

The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol (2010) 3.14

Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med (2012) 2.85

Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75

Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy (2011) 2.61

Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc (2011) 2.58

Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy (2013) 2.42

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis (2013) 2.39

The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med (2012) 2.36

Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc (2010) 2.34

Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: an experimental study in an animal model. Arthroscopy (2012) 2.32

Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg Am (2012) 2.31

Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med (2003) 2.19

Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol (2007) 1.98

NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets (2010) 1.89

Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood (2010) 1.81

Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med (2012) 1.81

Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther (2012) 1.79

Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci U S A (2004) 1.76

Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med (2011) 1.75

Platelets, inflammation and tissue regeneration. Thromb Haemost (2011) 1.69

The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum (2001) 1.64

Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways. J Biol Chem (2009) 1.60

Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med (2010) 1.60

Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells (2004) 1.59

Platelets and wound healing. Front Biosci (2008) 1.56

The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage (2010) 1.53

Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum (2010) 1.52

The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood (2000) 1.52

A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy (2012) 1.51

Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report. Knee Surg Sports Traumatol Arthrosc (2010) 1.51

Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol (2009) 1.49

The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop (2009) 1.49

The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum (2006) 1.46

Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol Biol Cell (2001) 1.45

Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs (2008) 1.43

Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol (2003) 1.42

Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol (2010) 1.42

CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol (2010) 1.41

Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) (2007) 1.41

Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med (2011) 1.40

Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost (2007) 1.40

Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis (2010) 1.37

Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat Rev Rheumatol (2011) 1.34

Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health (2012) 1.33

Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford) (2011) 1.30

The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J (2008) 1.29

Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials (2012) 1.28

IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One (2011) 1.27

Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol (2009) 1.25

Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage (2008) 1.24

Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg (2010) 1.24

Angiogenesis in osteoarthritis. Curr Opin Rheumatol (2008) 1.21

Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif (2009) 1.21

Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost (2010) 1.20

Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J Orthop Res (2011) 1.19

Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes. Rheumatology (Oxford) (2010) 1.19

Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Mod Rheumatol (2004) 1.17

Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord (2010) 1.15

Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am J Physiol Cell Physiol (2009) 1.13

The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. Cytokine Growth Factor Rev (2010) 1.12

Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem (2004) 1.12

Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One (2009) 1.12

Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One (2010) 1.10

The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol (2008) 1.10

Age-dependent alteration of TGF-β signalling in osteoarthritis. Cell Tissue Res (2011) 1.10

Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem (2009) 1.09

Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol (2012) 1.06

A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res (2011) 1.06

Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther (2010) 1.06

Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage (2007) 1.06

High throughput generated micro-aggregates of chondrocytes stimulate cartilage formation in vitro and in vivo. Eur Cell Mater (2012) 1.03

Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am (2012) 1.03

Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood (2011) 1.02

Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol (2010) 1.02

The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartilage (2012) 1.02

Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials (2005) 1.01

Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials (2011) 1.01

Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thromb Haemost (2010) 1.01

Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis (2011) 0.99

Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem (2004) 0.99

Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes. J Orthop Res (2011) 0.98

Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther (2012) 0.98

Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum (2011) 0.98

CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology (2011) 0.97

Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med (2008) 0.97

Platelets display potent antimicrobial activity and release human beta-defensin 2. Platelets (2011) 0.96

Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cell Mol Life Sci (2010) 0.96

Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs (2009) 0.95

Synovial membrane-derived mesenchymal stem cells supported by platelet-rich plasma can repair osteochondral defects in a rabbit model. Arthroscopy (2013) 0.94

Time-sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures. Mol Cell Biochem (2011) 0.93

Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J Orthop Res (2010) 0.93

Articles by these authors

(truncated to the top 100)

Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg Am (2005) 3.55

Eccentric loading, shock-wave treatment, or a wait-and-see policy for tendinopathy of the main body of tendo Achillis: a randomized controlled trial. Am J Sports Med (2007) 2.77

Ultrasound as a primary evaluation tool of bone stress injuries in elite track and field athletes. Am J Sports Med (2012) 2.75

Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med (2010) 2.26

Biochemical markers of muscular damage. Clin Chem Lab Med (2010) 2.25

Eccentric loading compared with shock wave treatment for chronic insertional achilles tendinopathy. A randomized, controlled trial. J Bone Joint Surg Am (2008) 2.24

Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene. Knee Surg Sports Traumatol Arthrosc (2009) 2.15

IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med (2010) 2.15

Trauma and orthopaedic training in the United Kingdom. J Bone Joint Surg Am (2002) 2.11

Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull (2010) 2.09

Creatine kinase monitoring in sport medicine. Br Med Bull (2007) 2.00

How successful are current ankle replacements?: a systematic review of the literature. Clin Orthop Relat Res (2009) 2.00

Quantitative review of operative and nonoperative management of achilles tendon ruptures. Am J Sports Med (2002) 1.82

Equivalent clinical results of arthroscopic single-row and double-row suture anchor repair for rotator cuff tears: a randomized controlled trial. Am J Sports Med (2007) 1.81

Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med (2012) 1.81

Surgery for ACL deficiency in patients over 50. Knee Surg Sports Traumatol Arthrosc (2010) 1.75

The effectiveness of arts-based interventions in medical education: a literature review. Med Educ (2011) 1.71

Evolving trauma and orthopedics training in the UK. J Surg Educ (2012) 1.69

Rating systems for evaluation of the elbow. Br Med Bull (2008) 1.68

Plantar fascia-specific stretching versus radial shock-wave therapy as initial treatment of plantar fasciopathy. J Bone Joint Surg Am (2010) 1.67

The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol (2007) 1.64

Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res (2014) 1.64

Tenotomy versus tenodesis in the management of pathologic lesions of the tendon of the long head of the biceps brachii. Am J Sports Med (2008) 1.62

Low-energy extracorporeal shock wave therapy as a treatment for medial tibial stress syndrome. Am J Sports Med (2009) 1.55

Magnetic resonance imaging versus arthroscopy in the diagnosis of knee pathology, concentrating on meniscal lesions and ACL tears: a systematic review. Br Med Bull (2007) 1.52

Management of tendinopathy. Am J Sports Med (2009) 1.52

Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin (2005) 1.51

Selective Kirschner wiring for displaced distal radial fractures in children. Acta Orthop Traumatol Turc (2010) 1.45

Epidemiology of injury in child and adolescent sports: injury rates, risk factors, and prevention. Clin Sports Med (2008) 1.45

Eccentric calf muscle training in non-athletic patients with Achilles tendinopathy. J Sci Med Sport (2006) 1.44

The effect of magnetic resonance imaging scans on knee arthroscopy: randomized controlled trial. Arthroscopy (2007) 1.43

Appropriate informed consent, then randomization is the only ethical way! Arthroscopy (2007) 1.39

A European ACL register. Knee Surg Sports Traumatol Arthrosc (2007) 1.38

Signal or noise, a statistical perspective. Proc Natl Acad Sci U S A (2014) 1.36

Physiopathology of intratendinous calcific deposition. BMC Med (2012) 1.35

Histopathology of the supraspinatus tendon in rotator cuff tears. Am J Sports Med (2007) 1.29

Prevention of adhesions in surgery of the flexor tendons of the hand: what is the evidence? Br Med Bull (2009) 1.29

Tendon augmentation grafts: a systematic review. Br Med Bull (2010) 1.28

Genetics and epidemiology of idiopathic congenital talipes equinovarus. J Pediatr Orthop (2003) 1.27

Reinjury after acute posterior thigh muscle injuries in elite track and field athletes. Am J Sports Med (2010) 1.26

Posterior thigh muscle injuries in elite track and field athletes. Am J Sports Med (2010) 1.26

No advantages in repairing a type II superior labrum anterior and posterior (SLAP) lesion when associated with rotator cuff repair in patients over age 50: a randomized controlled trial. Am J Sports Med (2007) 1.25

Eccentric loading versus eccentric loading plus shock-wave treatment for midportion achilles tendinopathy: a randomized controlled trial. Am J Sports Med (2008) 1.25

Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clin Orthop Relat Res (2008) 1.25

Calcific tendinopathy of the rotator cuff tendons. Sports Med Arthrosc (2011) 1.23

Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome. Am J Sports Med (2009) 1.22

Autologous platelet rich plasma for arthroscopic rotator cuff repair. A pilot study. Disabil Rehabil (2008) 1.19

Biomechanics and pathophysiology of overuse tendon injuries: ideas on insertional tendinopathy. Sports Med (2004) 1.19

Functional anatomy of the Achilles tendon. Knee Surg Sports Traumatol Arthrosc (2010) 1.19

Meniscectomy as a risk factor for knee osteoarthritis: a systematic review. Br Med Bull (2011) 1.18

Minimally invasive locked plating of distal tibia fractures is safe and effective. Clin Orthop Relat Res (2009) 1.17

Epidemiology of sprains of the lateral ankle ligament complex. Foot Ankle Clin (2006) 1.16

Extra-osseous osteochondroma-like soft tissue mass of the patello-femoral space. BMC Musculoskelet Disord (2006) 1.14

Acute muscle strain injuries: a proposed new classification system. Knee Surg Sports Traumatol Arthrosc (2012) 1.14

Femoroacetabular impingement syndrome management: arthroscopy or open surgery? Int Orthop (2011) 1.13

Protocol for the ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial: a pragmatic multi-centre randomised controlled trial of surgical versus non-surgical treatment for proximal fracture of the humerus in adults. BMC Musculoskelet Disord (2009) 1.13

Arthroscopic-assisted Broström-Gould for chronic ankle instability: a long-term follow-up. Am J Sports Med (2011) 1.11

Tissue engineered biological augmentation for tendon healing: a systematic review. Br Med Bull (2010) 1.10

Genetics and sports. Br Med Bull (2009) 1.09

Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in Osteoarthritis: Letter to the Editor. Am J Sports Med (2014) 1.09

The anterior cruciate ligament remnant: to leave it or not? Arthroscopy (2013) 1.08

Shock wave therapy for chronic plantar fasciopathy. Br Med Bull (2007) 1.08

Microfracture for chondral defects of the talus: maintenance of early results at midterm follow-up. Knee Surg Sports Traumatol Arthrosc (2010) 1.08

Ankle instability. Sports Med Arthrosc (2009) 1.08

Upper cervical spine injuries: indications and limits of the conservative management in Halo vest. A systematic review of efficacy and safety. Injury (2010) 1.07

Rating scales for low back pain. Br Med Bull (2010) 1.07

Ageing of human muscles and tendons. Disabil Rehabil (2008) 1.07

Recurrent subluxation of the peroneal tendons. Sports Med (2006) 1.07

Anterior cruciate ligament tears: what we already know. Knee Surg Sports Traumatol Arthrosc (2012) 1.07

Remplissage repair--new frontiers in the prevention of recurrent shoulder instability: a 2-year follow-up comparative study. Am J Sports Med (2012) 1.07

Minimally invasive total knee arthroplasty: a systematic review. Orthop Clin North Am (2009) 1.07

Anteromedial portal versus transtibial drilling techniques in anterior cruciate ligament reconstruction: any clinical relevance? A retrospective comparative study. Arthroscopy (2013) 1.07

Management of the greater trochanteric pain syndrome: a systematic review. Br Med Bull (2011) 1.07

Metalloproteases and rotator cuff disease. J Shoulder Elbow Surg (2012) 1.06

Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther (2010) 1.06

The effects of LIPUS on soft-tissue healing: a review of literature. Br Med Bull (2008) 1.05

Eosinophilic granuloma of the pediatric cervical spine. Spine (Phila Pa 1976) (2008) 1.05

The best surgical treatment for type II fractures of the dens is still controversial. Clin Orthop Relat Res (2011) 1.05

Reconstruction of the anterior cruciate ligament with a patella-tendon-bone graft may lead to a permanent loss of bone mineral content due to decreased patellar tendon stiffness. Med Hypotheses (2005) 1.05

Incidence and distribution of pediatric sport-related injuries. Clin J Sport Med (2006) 1.04

Arthroscopic classification of acetabular rim labrochondral disease. Am J Sports Med (2013) 1.04

Achilles tendinopathy. Sports Med Arthrosc (2009) 1.04

Medial patellofemoral ligament reconstruction: a new technique. BMC Musculoskelet Disord (2007) 1.04

Management of Achilles tendinopathy by ultrasound-guided percutaneous tenotomy. Med Sci Sports Exerc (2002) 1.03

High volume image guided injections in chronic Achilles tendinopathy. Disabil Rehabil (2008) 1.03

Inflammation in overuse tendon injuries. Sports Med Arthrosc (2011) 1.02

Tendinopathy of the tendon of the long head of the biceps. Sports Med Arthrosc (2011) 1.01

Percutaneous plating of the distal tibia. J Foot Ankle Surg (2004) 1.01

Acute ruptures of the achilles tendon. Sports Med Arthrosc (2009) 1.00

History and evolution in total ankle arthroplasty. Br Med Bull (2008) 1.00

The evidence of low-intensity pulsed ultrasound for in vitro, animal and human fracture healing. Br Med Bull (2011) 1.00

Hamstring exercises for track and field athletes: injury and exercise biomechanics, and possible implications for exercise selection and primary prevention. Br J Sports Med (2012) 0.99

Arthroscopic management of chronic patellar tendinopathy. Am J Sports Med (2011) 0.99

The FIFA 11+ program is effective in preventing injuries in elite male basketball players: a cluster randomized controlled trial. Am J Sports Med (2012) 0.99

Platelet-rich plasma for muscle injury and tendinopathy. Sports Med Arthrosc (2013) 0.99

Tendinopathy and tendon injury: the future. Disabil Rehabil (2008) 0.99

Conservative management of tendinopathy: an evidence-based approach. Muscles Ligaments Tendons J (2012) 0.99

Achilles tendon problems: not just an orthopaedic issue. Disabil Rehabil (2008) 0.99

Medial patellofemoral ligament reconstruction with a divergent patellar transverse 2-tunnel technique. Am J Sports Med (2011) 0.99

Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther (2012) 0.98